SCHEMBL9135015

SCHEMBL9135015

CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc2nc(-c3ccccc3)n(CC(=O)O)c2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 4/20 0.69
▸ KDM4E B2RXH2 2/20 0.69
▸ HSD17B10 Q99714 2/20 0.69
▸ ABCC3 O15438 1/20 0.69
▸ ABCC4 O15439 1/20 0.69
▸ USP2 O75604 1/20 0.69
▸ ABCB11 O95342 1/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ CHRM2 P08172 1/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ ADRA2A P08913 1/20 0.69
▸ ADORA3 P0DMS8 1/20 0.69
▸ CHRM1 P11229 1/20 0.69
▸ CYP2C9 P11712 1/20 0.69
▸ ACE P12821 1/20 0.69
▸ ADRA2C P18825 1/20 0.69
▸ TBXA2R P21731 1/20 0.69
▸ GLRA1 P23415 1/20 0.69
▸ PDE4A P27815 1/20 0.69
▸ HTR2A P28223 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9136803 0.94 PPARG (0.69) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL9139364 0.92 PPARG (0.66) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL7046615 0.89 PPARG (0.68) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL9136081 0.87 PPARG (0.63) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL9137178 0.87 PPARG (0.65) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL1249924 0.86 PPARG (0.78) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL29377244 0.85 PPARG (0.85) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL4565984 0.85 PPARG (0.85) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL9563095 0.85 PPARG (0.71) PPARGKDM4EHSD17B10ABCC3ABCC4
SCHEMBL13382771 0.84 PPARG (0.75) PPARGKDM4EHSD17B10ABCC3ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5459147-A Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma DR. KARL THOMAE GMBH (DE) 1995-10-17 — — US claimed
EP-0560330-A2 Substituted benzimidazolyl derivatives, therapeutic agents containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-09-15 — — EP claimed
US-5459147-A Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma DR. KARL THOMAE GMBH (DE) 1995-10-17 — — US disclosed
EP-0560330-A2 Substituted benzimidazolyl derivatives, therapeutic agents containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-09-15 — — EP disclosed
Send feedback